JPMorgan Chase & Co. trimmed its position in shares of Encompass Health Co. (NYSE:EHC – Free Report) by 4.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,969,266 shares of the company’s stock after selling 126,511 shares during the period. JPMorgan Chase & Co. owned 2.96% of Encompass Health worth $199,416,000 at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Encompass Health by 1.2% during the third quarter. Vanguard Group Inc. now owns 9,653,180 shares of the company’s stock worth $436,613,000 after acquiring an additional 111,745 shares in the last quarter. William Blair Investment Management LLC increased its holdings in Encompass Health by 6.4% in the third quarter. William Blair Investment Management LLC now owns 5,676,379 shares of the company’s stock worth $381,226,000 after buying an additional 342,512 shares during the last quarter. Invesco Ltd. grew its position in Encompass Health by 22.3% in the third quarter. Invesco Ltd. now owns 3,974,306 shares of the company’s stock worth $266,914,000 after acquiring an additional 724,544 shares in the last quarter. Baupost Group LLC MA increased its holdings in shares of Encompass Health by 318.9% during the 1st quarter. Baupost Group LLC MA now owns 3,000,000 shares of the company’s stock valued at $213,330,000 after acquiring an additional 2,283,900 shares during the last quarter. Finally, State Street Corp lifted its holdings in Encompass Health by 0.4% in the 1st quarter. State Street Corp now owns 2,871,705 shares of the company’s stock worth $155,787,000 after purchasing an additional 12,043 shares during the last quarter. 92.66% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
EHC has been the topic of several research reports. Mizuho boosted their price target on Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, February 9th. Truist Financial raised their target price on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Barclays assumed coverage on shares of Encompass Health in a research report on Wednesday, March 6th. They set an “overweight” rating and a $95.00 target price on the stock. William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Finally, Stephens restated an “overweight” rating and set a $85.00 price target on shares of Encompass Health in a research note on Tuesday, January 16th. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $82.56.
Read Our Latest Report on Encompass Health
Encompass Health Stock Performance
Shares of NYSE:EHC opened at $76.45 on Monday. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19. The stock has a market capitalization of $7.66 billion, a P/E ratio of 22.03, a P/E/G ratio of 1.42 and a beta of 0.93. The business has a 50-day moving average price of $72.02 and a two-hundred day moving average price of $68.23. Encompass Health Co. has a 1-year low of $51.15 and a 1-year high of $78.11.
Encompass Health (NYSE:EHC – Get Free Report) last released its earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.12. The firm had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.24 billion. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. Equities analysts predict that Encompass Health Co. will post 3.94 earnings per share for the current year.
Encompass Health Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 15th. Investors of record on Monday, April 1st will be paid a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, March 28th. This represents a $0.60 dividend on an annualized basis and a yield of 0.78%. Encompass Health’s payout ratio is 17.29%.
Encompass Health Profile
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Further Reading
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Encompass Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
